Abstract:OBJECTIVE:To explore the therapeutic efficacy of double suicide gene system driven by carcinoembryonic antigen (CEA) promoter (Cp-CDglyTK) on colorectal carcinoma xenograft in nude mice. METHODS:The plasmid pcDNA3.1(-)Cp-CDglyTK was transfected into the CEA-positive SW480 and CEA-negative HeLa cells respectively. The expression of suicide gene was detected by RT-PCR. And the transfected cells were treated with 5-fluorocytosine (5-FC) and ganciclovir (GCV) at different concentrations and the cell-killing and bystander effects assayed by methyl thiazolyl tetrazolium (MTT). By a transplantation of cultivated cells, SW480 or HeLa cell lines were injected subcutaneously into right axillary of nude mice to establish 96 SW480 and 72 HeLa tumor animal models. Nude mice were completely randomized with statistical software according to tumor volume. For prodrug therapy, 48 SW480-bearing mice were divided equally into 4 groups of I-IV. At the same time, 48 HeLa-bearing mice were divided equally into 4 groups of V-VIII. Groups I & V received an intratumoral injection of PBS, groups II & VIGCV and 5-FC intratumorally, groups III & VII PBS intraperitoneally and groups IV & VIII GCV and 5-FC intraperitoneally. Forty-eight SW480-bearing mice were divided equally into 4 groups of IX∼XII and 24 Hela-bearing ones into groups of & in therapy experiment by suicide gene plus prodrug. Six groups received an intratumoral injection of liposome Lipofectamine and plasmid CP-CDglyTK and then an intraperitoneal injection of drug. The groups of IX and received an injection of PBS, group X GCV, group XI 5-FC and groups XII & GCV and 5-FC. The observation parameters included tumor bulk, tumor weight, survival time and treatment effect in each group. RESULTS:SW480 cells transfected by plasmid pcDNA3.1(-)Cp- CDglyTK expressed CDglyTK gene. The inhibition rates of GCV and 5-FC were significantly higher than those of HeLa cells (59.87% ± 0.21% vs 9.90% ± 0.09%, P < 0.01). And higher inhibition rates and stronger bystander effect existed in double versus single produg (all P < 0.05). Tumor size, final tumor weight and survival time of nude mice in groups ofII, IV, VI & VIII had no significant difference with groups ofI, III, V & VII (all P < 0.05). Final tumor size and weight of group XII was significantly smaller than those of groups of IX, X and XI ((150.0 ± 3.2) vs (522.5 ± 1.9) and (256.8 ± 10.4) and (260.7 ± 2.2) mm(3), (54.1 ± 10.4) vs (682.0 ± 12.0) and (251.8 ± 15.1) and (271.6 ± 17.7) mg, all P < 0.05). Meanwhile, the tumor inhibition rate and survival time of group XII(92.1% and (25.7 ± 0.8)d) were significant higher and longer than group X (63.1% and (21.8 ± 0.5) d) and group XI (60.2% and (18.0 ± 0.9) d) (all P < 0.05). However, no significant difference existed in tumor size, final tumor weight and survival time between groups and (all P > 0.05). The inhibition rate of group was merely 0.9%. CONCLUSION:CDglyTK double suicide gene system driven by CEA promoter may inhibit CEA positive colorectal cancer xenograft in prodrug-treated nude mice.

[Synergistic Use of Epidermal Growth Factor and 5-Fluorouracil for the Treatment of Human Colorectal Cancer in BALB/C Nude Mice Subcutaneous Xenograft Model].

[RAD001 Reverses Radio-Resistance and Exerts Synergistic Tumor Inhibition with 5-Fluorouracil].

Effection of Celecoxib Combined with 5-Fu on Treatmeat of Human Colorectal Cancer in BALB/C Nude Mice Subcutaneous Xenograft Model

Synergistic anti-tumorigenic effect of diosmetin in combination with 5-fluorouracil on human colon cancer xenografts in nude mice

Reduction of G0 phase cells of colon cancer caco-2 cells may enhance 5-fluorouracil efficacy.

[Influence of Combination of Low Dosage 131I-Labeled Anti-Carcinoembryonic Antigen Antibody C50 and 5-Fluorouracil on Tumor Growth of Colorectal Cancer Xenografts in Nude Mice].

Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.

Increase of Cyclooxygenase-2 Inhibition with Celecoxib Combined with 5-FU Enhances Tumor Cell Apoptosis and Antitumor Efficacy in a Subcutaneous Implantation Tumor Model of Human Colon Cancer

Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice

Synergistic Anticancer Effect of Exogenous Wild-Type P53 Gene Combined with 5-Fu in Human Colon Cancer Resistant to 5-Fu in Vivo

Inhibition Effect to Colorectal Cancer Induced by Synergistic Usage of Celecoxib and 5-FU and Its Mechanism

Tenacissoside G Synergistically Potentiates Inhibitory Effects of 5-Fluorouracil to Human Colorectal Cancer.

[Cytosine Deaminase and Thymidine Kinase Double Suicide Gene System Driven by Carcinoembryonic Antigen Promoter for the Treatment of Colorectal Carcinoma Xenograft in Nude Mice].

Effect of 1,25-Dihydroxyvitamin D3 Combined with 5-Fluorouracil on IGFBP-3 Expression in Human Esophageal Carcinoma 109 Cell Xenograft in Nude Mice

Impact of 5-Fu/oxaliplatin on Mouse Dendritic Cells and Synergetic Effect with a Colon Cancer Vaccine.

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma

Synergistic Antitumor Effect Of 20-(R)-Rg(3) Combined With 5-Fluorouracil On Hct-116 Cell

Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer

Feng-liao-chang-wei-kang is Synergistic with 5-Fluorouracil in Inhibiting Proliferation of Colorectal Cancer

Synergistic Effect of Triptolide Combined with 5-Fluorouracil on Colon Carcinoma.

[Anticancer Efficacy of Combining Cytosine Deaminase/5-Fluorocytosine Gene Therapy and Radiotherapy on Cervical Carcinoma].